Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Compass Therapeutics, Inc. (CMPX)
|
Add to portfolio |
|
|
|
| Price: |
$3.45
| | Metrics |
| OS: |
127.5
|
M
| |
|
|
| Market cap: |
$440
|
M
| |
|
|
|
Net cash:
|
$169
|
M
| |
$1.32
|
per share
|
|
EV:
|
$271
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($40.9)
|
M
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Mar-31-20 | Dec-31-19 | Mar-31-19 | Dec-31-18 |
| Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Selling, general and administrative | | | 27.8 | | | | |
| Research and development | 30.0 | 20.3 | 14.9 | | 22.4 | | 27.1 |
| General and administrative | 11.7 | 10.9 | | 0.0 | 11.6 | 0.0 | 11.2 |
| EBIT | -41.7 | -31.3 | 0.0 | 0.0 | -34.1 | 0.0 | -38.3 |
| Pre-tax income | -39.2 | -82.2 | -29.5 | 0.0 | -34.7 | 0.0 | -38.2 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 |
| Tax rate | 0.0% | 0.0% | | 0.0% | | 0.0% | |
| Net income | -39.2 | -82.2 | -29.5 | 0.0 | -34.7 | 0.0 | -38.3 |
| |
| Diluted EPS | ($0.37) | ($1.31) | ($0.96) | ($0.01) | ($5.19) | ($0.01) | |
| Shares outstanding (diluted) | 105.2 | 62.9 | 30.8 | 5.0 | 6.7 | 5.0 | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|